Published: May 7, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, Tremelimumab, P-III, POSEIDON Study, Stage IV Non-Small Cell Lung Cancer
Published: May 7, 2021 | Tags: Merck, Fusion Pharmaceuticals, FPI-1434, Keytruda, pembrolizumab, Solid Tumors, IGF-1R
BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative
Published: May 7, 2021 | Tags: BMS, DarwinHealth, Novel Cancer Target Initiative
Published: May 7, 2021 | Tags: BeiGene, Asieris, APL-1202, Tislelizumab, Muscle Invasive Bladder Cancer
Published: May 7, 2021 | Tags: AbCellera, Amgen, Bispecific Antibodies, Diabetic Retinopathy
Published: May 7, 2021 | Tags: Merck, Eisai, US, FDA, Priority Review, Keytruda, pembrolizumab, Lenvima, Lenvatinib, Applications, Advanced Renal Cell Carcinoma, Endometrial Carcinoma
Published: May 6, 2021 | Tags: Amgen, US, FDA, Acceptance, sNDA, Review, Otezla, apremilast, Plaque Psoriasis
Roche’s Ab Cocktail (Casirivimab and Imdevimab) Receives EUA to Treat COVID-19 in India
Published: May 6, 2021 | Tags: Roche, Ab Cocktail, Casirivimab, Imdevimab, EUA, COVID-19
Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research
Published: May 6, 2021 | Tags: Sanofi, Stanford Medicine, Accelerate, Immunology Research
Medtronic Launches CareGuidePro App for Managing Spinal Cord Stimulation
Published: May 6, 2021 | Tags: Medtronic, CareGuidePro App, Managing, Spinal Cord Stimulation
Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test
Published: May 6, 2021 | Tags: Phenomix, Mayo Clinic, AI-Powered, Obesity, Phenotype Blood Test
GSK’s Benlysta (belimumab) Receives EC’s Approval for the Treatment of Active Lupus Nephritis
Published: May 6, 2021 | Tags: GSK, Benlysta, belimumab, EC, Approval, Active Lupus Nephritis
Exelixis Acquires GamaMabs’ Oncology Antibody Program to Expand its Biotherapeutics Portfolio
Published: May 5, 2021 | Tags: Exelixis, GamaMabs, Oncology Antibody Program, Biotherapeutics Portfolio
Published: May 5, 2021 | Tags: ProQR Therapeutics, Yarrow, Therapies, Non-Ophthalmic Target
AbCellera to Initiate Clinical Trial of LY-CoV1404 Against Viral Variants of COVID 19
Published: May 5, 2021 | Tags: AbCellera, Clinical Trial, LY-CoV1404, Against, Viral Variants, COVID 19
Published: May 5, 2021 | Tags: Amgen, Amgevita, biosimilar, adalimumab, Multiple Chronic Inflammatory Diseases
Roche’s Tecentriq Receives EC’s Approval as 1L Treatment for Metastatic Non-Small Cell Lung Cancer
Published: May 5, 2021 | Tags: Roche, Tecentriq, EC, Approval, Metastatic Non-Small Cell Lung Cancer
Athenex to Acquire Kuur Therapeutics for ~$185M
Published: May 5, 2021 | Tags: Athenex, Kuur Therapeutics, ~$185M
Published: May 4, 2021 | Tags: Vaxart, VXA-CoV2-1, Oral COVID-19 Vaccine, P-I, Trial, Against, Other Coronaviruses
Novavax Reports the Pediatric Expansion for P-III Clinical Trial of NVX-CoV2373 Against COVID-19
Published: May 4, 2021 | Tags: Novavax, Pediatric Expansion, P-III, Clinical Trial, NVX-CoV2373, COVID-19
Published: May 4, 2021 | Tags: BMS, Mavacamten, Obstructive Hypertrophic Cardiomyopathy, ACC 2021
Published: May 4, 2021 | Tags: Sandoz, Proposed, Biosimilar, Aflibercept, P-III, MYLIGHT Study, Neovascular Age-Related Macular Degeneration
Labcorp to Acquire Myriad’s Vectra Testing Business for $150M
Published: May 4, 2021 | Tags: Labcorp, Myriad, Vectra Testing Business, $150M
Roivant Going Public Via MAAC SPAC Merger for ~$7.3B
Published: May 4, 2021 | Tags: Roivant, MAAC SPAC, Merger,~$7.3B
Published: May 3, 2021 | Tags: Eli Lilly, Incyte, Olumiant, baricitinib, P-III, BREEZE-AD5 Trial, Atopic Dermatitis, AAD2021
Published: May 3, 2021 | Tags: Guardant Health, Blood-Only, Liquid Biopsy Test, Colorectal Cancer Recurrence
Published: May 3, 2021 | Tags: Sobi, Hellenic Institute, Anakinra, P-III, SAVE-MORE Study, COVID-19 Pneumonia
Published: May 3, 2021 | Tags: Novartis, Beovu, brolucizumab -dbll, P-III, KESTREL, KITE Studies, Diabetic Macular Edema, ARVO2021
Samsung Bioepis Presents Results of SB11 (proposed biosimilar ranibizumab) at ARVO 2021
Published: May 3, 2021 | Tags: Samsung Bioepis, SB11, biosimilar, ranibizumab, ARVO 2021
AstraZeneca’s Farxiga (dapagliflozin) Receives the US FDA’s Approval for Chronic Kidney Disease
Published: May 3, 2021 | Tags: AstraZeneca, Farxiga, dapagliflozin, US, FDA, Approval, Chronic Kidney Disease
Related Post: PharmaShots Weekly Snapshots (Apr 26 – 30, 2021)
The post PharmaShots Weekly Snapshots (May 03 – 07, 2021) first appeared on PharmaShots.